These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3476353)

  • 21. [Acute lymphoblastic leukemia: results of treatment in 130 children].
    Quintana J; Beresi V; del Pozo H; Schuh W; Del Borgo P; Koporcic M; Arroyo M; Avayú E; Montero T
    Rev Chil Pediatr; 1987; 58(3):219-24. PubMed ID: 3483472
    [No Abstract]   [Full Text] [Related]  

  • 22. Curing children of leukemia.
    Pinkel D
    Cancer; 1987 May; 59(10):1683-91. PubMed ID: 3470109
    [No Abstract]   [Full Text] [Related]  

  • 23. Acute leukaemia in the elderly, remission induction versus palliative therapy.
    Smith AG; Whitehouse JM; Roath OS; Williams CJ; Mead GM
    Haematol Blood Transfus; 1987; 30():330-2. PubMed ID: 2442073
    [No Abstract]   [Full Text] [Related]  

  • 24. [Corticosteroid-dependent reduction of leukocyte count in blood as a prognostic factor in acute lymphoblastic leukemia in childhood (therapy study ALL-BFM 83)].
    Riehm H; Reiter A; Schrappe M; Berthold F; Dopfer R; Gerein V; Ludwig R; Ritter J; Stollmann B; Henze G
    Klin Padiatr; 1987; 199(3):151-60. PubMed ID: 3306129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Results of the treatment of lymphoblastic leukemia by the BFM program in children--a 5-year observation].
    Rokicka-Milewska R; Derulska D; Makowska K; Skwarska E; Lewicki Z
    Acta Haematol Pol; 1987; 18(1-2):1-8. PubMed ID: 3481150
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of risk grouping methods for acute lymphoblastic leukemia in children.
    Nishi M; Miyake H; Takeda T
    Jpn J Clin Oncol; 1988 Jun; 18(2):125-34. PubMed ID: 3164078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early intensification therapy in high-risk childhood acute lymphocytic leukemia: lack of benefit from high-dose methotrexate.
    Janka GE; Winkler K; Juergens H; Goebel U
    Haematol Blood Transfus; 1987; 30():456-60. PubMed ID: 3476379
    [No Abstract]   [Full Text] [Related]  

  • 28. [Consolidating chemotherapy in the treatment program of acute lymphoblastic leukemia in children].
    Maiakova SA; Makhonova LA
    Vestn Akad Med Nauk SSSR; 1986; (5):15-7. PubMed ID: 3487897
    [No Abstract]   [Full Text] [Related]  

  • 29. Influence of intensive induction and consolidation therapy in acute lymphoblastic leukaemia in children.
    Sanchetee SC; Pai SK; Pai VR; Kurkure PA; Shetty PA
    Indian J Cancer; 1985 Sep; 22(3):217-20. PubMed ID: 3870462
    [No Abstract]   [Full Text] [Related]  

  • 30. How should acute lymphoblastic leukaemia relapsing after bone-marrow transplantation be treated?
    Barrett AJ; Joshi R; Tew C
    Lancet; 1985 May; 1(8439):1188-91. PubMed ID: 2860389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of acute lymphoblastic leukemia in children].
    Schaison G; Leverger G
    Rev Prat; 1986 Sep; 36(37):2179-86. PubMed ID: 3554475
    [No Abstract]   [Full Text] [Related]  

  • 32. Stratification by prognostic factors in the design and analysis of clinical trials for acute lymphoblastic leukemia.
    Hammond GD; Sather H; Bleyer WA; Coccia P
    Haematol Blood Transfus; 1987; 30():161-6. PubMed ID: 3305192
    [No Abstract]   [Full Text] [Related]  

  • 33. Acute lymphoblastic leukemia of childhood.
    Cohen DL; Duval-Arnould B; Olson TA
    Am Fam Physician; 1984 Oct; 30(4):236-45. PubMed ID: 6388294
    [No Abstract]   [Full Text] [Related]  

  • 34. [Results of 2 protocols in the treatment of acute lymphoid leukemia in children, according to prognostic factors].
    Misset JL; Gil-Delgado MA; Delgado M; de Vassal F; Machover D; Goutner A; Mathé G
    Rev Esp Oncol; 1982; 29(4):785-801. PubMed ID: 6965045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Factors influencing the prognosis of lymphoblastic leukemia in children].
    Vargas L; Barría M; Young T; Pino S; García H
    Rev Chil Pediatr; 1984; 55(3):156-63. PubMed ID: 6594727
    [No Abstract]   [Full Text] [Related]  

  • 36. Improved treatment results in the myelocytic subtypes FAB M1-M4 but not in FAB M5 after intensification of induction therapy: results of the German childhood AML studies BFM-78 and BFM-83.
    Ritter J; Creutzig U; Schellong G
    Haematol Blood Transfus; 1990; 33():185-92. PubMed ID: 2182410
    [No Abstract]   [Full Text] [Related]  

  • 37. [10-year analysis (1969-1978) of the results of treating children with acute lymphoblastic leukemia--therapeutic implications].
    Schulz M; Blau HJ; Töwe J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(6):822-30. PubMed ID: 6200393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical experiences with a modified BFM protocol in childhood acute lymphoblastic leukemia.
    Zintl F; Malke H; Plenert W
    Haematol Blood Transfus; 1985; 29():84-9. PubMed ID: 3896979
    [No Abstract]   [Full Text] [Related]  

  • 39. Rapidly rotating combination chemotherapy in childhood acute lymphoblastic leukemia: preliminary results of a randomized comparison with conventional treatment.
    Janka-Schaub GE; Winkler K; Göbel U; Graubner U; Gutjahr P; Haas RJ; Jürgens H; Spaar J
    Leukemia; 1988 Dec; 2(12 Suppl):73S-78S. PubMed ID: 3199881
    [No Abstract]   [Full Text] [Related]  

  • 40. [Current status of the biology and therapy of acute lymphatic leukemia (ALL) in childhood. 2: Therapy of ALL].
    Zintl F
    Kinderarztl Prax; 1986 Mar; 54(3):111-6. PubMed ID: 3458968
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.